Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMITRIPTYLINE Cause Therapy non-responder? 144 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Therapy non-responder have been filed in association with AMITRIPTYLINE (AMITRIPTYLINE HYDROCHLORIDE). This represents 0.7% of all adverse event reports for AMITRIPTYLINE.

144
Reports of Therapy non-responder with AMITRIPTYLINE
0.7%
of all AMITRIPTYLINE reports
14
Deaths
44
Hospitalizations

How Dangerous Is Therapy non-responder From AMITRIPTYLINE?

Of the 144 reports, 14 (9.7%) resulted in death, 44 (30.6%) required hospitalization, and 20 (13.9%) were considered life-threatening.

Is Therapy non-responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMITRIPTYLINE. However, 144 reports have been filed with the FAERS database.

What Other Side Effects Does AMITRIPTYLINE Cause?

Toxicity to various agents (3,001) Drug ineffective (2,344) Completed suicide (1,678) Off label use (1,588) Pain (1,300) Fall (1,216) Hypotension (1,205) Drug abuse (1,116) Dizziness (1,041) Constipation (1,035)

What Other Drugs Cause Therapy non-responder?

ETANERCEPT (3,472) APREMILAST (3,360) METHOTREXATE (2,965) RITUXIMAB (2,731) ADALIMUMAB (2,595) PREDNISONE (2,563) TREPROSTINIL (2,289) INFLIXIMAB (2,122) TOCILIZUMAB (1,775) HYDROXYCHLOROQUINE (1,699)

Which AMITRIPTYLINE Alternatives Have Lower Therapy non-responder Risk?

AMITRIPTYLINE vs AMITRIPTYLINE\PERPHENAZINE AMITRIPTYLINE vs AMIVANTAMAB AMITRIPTYLINE vs AMIVANTAMAB-VMJW AMITRIPTYLINE vs AMLODIPINE AMITRIPTYLINE vs AMLODIPINE BESILATE

Related Pages

AMITRIPTYLINE Full Profile All Therapy non-responder Reports All Drugs Causing Therapy non-responder AMITRIPTYLINE Demographics